Arcus Capital Partners, LLC Merck & Co., Inc. Transaction History

Arcus Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $13,246 - $14,226	-107 Reduced 6.14%	1,635 $202,000
Q1 2024 Apr 19, 2024	BUY	$113.24 - $131.95 $197,264 - $229,856	1,742 New	1,742 $229,000
Q4 2022 Jan 27, 2023	BUY	$87.44 - $112.11 $142,964 - $183,299	1,635 New	1,635 $0
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $213,791 - $248,101	3,277 New	3,277 $250,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Arcus Capital Partners, LLC with notifications on news.